On July 13, in connection with the Abioplus-Interpex Korea 2023 event, the Microbiome New Drug Business Council inaugural meeting and inauguration ceremony were held.

Starting with the seminar held last April, a total of 27 companies related to microbiome new drugs, including a total of 6 steering committee members, gathered to form a council.

The steering committee members include HEM Pharma, CJ Bioscience, Genome & Company, Kobio Lab, ImmunoBiome, and Chong Kun Dang Bio.

It is composed of leading companies in the microbiome industry.

After the inauguration ceremony, discussions were held on detailed measures necessary for the development of the domestic microbiome, led by CEO Yosep Ji 

and the representatives of the steering committee.

Starting with this inauguration ceremony, we are preparing for the next seminar.

We plan to promote the development of microbiome new drugs and resolve issues.

Read More >> Microbiome companies unite… New drug development ‘speed’ with the launch of the council (edaily.co.kr)